Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Regression Models and Life-Tables

1972 • 27,145 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

1978 • 4,673 citations

Note on the sampling error of the difference between correlated proportions or percentages

1947 • 3,814 citations

National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage

1982 • 3,027 citations

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1998 • 2,777 citations

Characterization of a human B lymphocyte-specific antigen.

1980 • 1,098 citations

High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

1987 • 797 citations

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

1986 • 704 citations

Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support

1993 • 665 citations

CD20: a regulator of cell-cycle progression of B lymphocytes

1994 • 583 citations

Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies

1998 • 576 citations

Radioimmunotherapy of B-Cell Lymphoma with [¹³¹I]Anti-B1 (Anti-CD20) Antibody

1993 • 557 citations

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas

1995 • 447 citations

Follicular lymphoma: prognostic factors for response and survival.

1986 • 444 citations

A clinical trial of anti-idiotype therapy for B cell malignancy

1985 • 434 citations

Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen.

1980 • 413 citations

Natural history of and therapy for the indolent non-Hodgkin's lymphomas.

1993 • 412 citations

Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.

1996 • 410 citations

Treatment of Non-Hodgkin's Lymphoma

1993 • 387 citations

Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas

1987 • 360 citations

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype

1989 • 356 citations

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.

1996 • 336 citations

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.

1998 • 300 citations

Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains.

1988 • 280 citations

Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies.

1989 • 255 citations

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

1987 • 245 citations

Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.

1991 • 204 citations

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.

1998 • 189 citations

Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.

1987 • 188 citations

Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon

1989 • 182 citations

Retention of B-cell-specific monoclonal antibodies by human lymphoma cells

1994 • 163 citations

Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.

1992 • 156 citations

Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes

1986 • 146 citations

Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody.

1995 • 116 citations

Patient-specific whole-body dosimetry: principles and a simplified method for clinical implementation.

1998 • 115 citations

Fractionated radioimmunotherapy of B-cell malignancies with 131I-Lym-1.

1990 • 111 citations

Iodine-131 anti-B1 antibody for B-cell lymphoma: an update on the Michigan Phase I experience.

1998 • 90 citations

The Comparison of Survival Curves

1959 • 89 citations

Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.

1992 • 89 citations

Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti- idiotype monoclonal antibodies

1996 • 73 citations

Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma.

1993 • 68 citations

Increased survival associated with radiolabeled lym-1 therapy for non-hodgkin's lymphoma and chronic lymphocytic leukemia

1997 • 65 citations

Revised Nuclear Regulatory Commission regulations for release of patients administered radioactive materials: outpatient iodine-131 anti-B1 therapy.

1998 • 44 citations

Inhibition of autoradiolysis of radiolabeled monoclonal antibodies by cryopreservation.

1990 • 40 citations

Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapy.

1998 • 40 citations

A Phase I Escalating-Dose Safety, Dosimetry and Efficacy Study of Radiolabeled Monoclonal Antibody LYM-1

1993 • 30 citations

High-dose therapy and transplantation in non-Hodgkin's lymphoma.

1999 • 17 citations